ARTICLE | Financial News
Laekna raises $18.5M series A
June 8, 2018 6:28 PM UTC
Laekna Therapeutics Shanghai Co. Ltd. (Shanghai, China) raised $18.5 million in a series A round led by OrbiMed Asia, with participation from AnlongMed.
Laekna said it has three candidates in Phase I-II testing to treat various cancers and drug discovery programs in cancer and liver disease, including non-alcoholic steatohepatitis (NASH) and hepatic cirrhosis...
BCIQ Company Profiles